Answer
Azacitidine (Vidaza) is associated with anaemia, neutropenia and thrombocytopenia, particularly during the first two treatment cycles.
Sources for this answer
- Vidaza 25 mg/ml powder for suspension for injectionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 25Document updated
Sources checked